Rigel Pharmaceuticals
RIGL
#7467
Rank
NZ$0.55 B
Marketcap
$30.80
Share price
-2.35%
Change (1 day)
43.62%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): NZ$44.22 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.17 Billion. , an increase over its 2023 earnings that were of -NZ$32.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 NZ$46.96 M-244.27%
2023 -NZ$32.56 Million-66.79%
2022 -NZ$98.03 Million340.73%
2021 -NZ$22.25 Million-56.15%
2020 -NZ$50.73 Million-57.34%
2019 -NZ$0.12 Billion-7.66%
2018 -NZ$0.13 Billion-9.47%
2017 -NZ$0.15 Billion24.46%
2016 -NZ$0.12 Billion23.63%
2015 -NZ$92.45 Million-43.29%
2014 -NZ$0.17 Billion2.5%
2013 -NZ$0.16 Billion
2010 NZ$67.64 M-133.97%
2009 -NZ$0.2 Billion-18.49%
2008 -NZ$0.25 Billion71.91%
2007 -NZ$0.15 Billion84.74%
2006 -NZ$76.92 Million-10.17%
2005 -NZ$85.63 Million-15.73%
2004 -NZ$0.11 Billion39.29%
2003 -NZ$72.95 Million10.3%
2002 -NZ$66.14 Million48.3%
2001 -NZ$44.6 Million-2.13%
2000 -NZ$45.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion-596.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.18 Billion-474.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.64 B 39,593.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$8.23 B 17,435.38%๐Ÿ‡บ๐Ÿ‡ธ USA